First Elizabeth Holmes is back with her husband's new blood testing venture, and now Neumann!

> "Flow seemed overvalued — it had a $1 billion valuation right off the bat, thanks in part to $350 million from Andreessen Horowitz’s a16z venture-capital firm, the largest single investment the firm had made at that point."